Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StoneBridge Pharma was a specialty pharmaceutical company based in Parsippany, New Jersey, that focused on the respiratory and pediatric therapeutic areas. The company specialized in the commercialization of prescription products for the treatment of cough, cold, and allergy symptoms. Its portfolio included several established brands such as M-End, Ed-Chlo, and Z-Cof. In April 2009, StoneBridge Pharma was acquired by Shionogi Inc., the U.S. subsidiary of the Japanese pharmaceutical company Shionogi & Co., Ltd. This acquisition served as a strategic move for Shionogi to bolster its commercial footprint in the United States. Following the acquisition, StoneBridge's products were integrated into Shionogi's existing respiratory portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StoneBridge Pharma.